Anesthesiology & Analgesia
Ear, Nose & Throat
O&G and Peri-Natal
Patient Support System
Physio & Rehab
Innonix Technologies Inc. is based in Hong Kong, with its R&D team in the US and HK, and Marketing & Distribution offices in the US and Singapore.
The company has developed many products in its portfolio. Among its products, the most recent is an anti-pollution face mask, which in addition to blocking the PM2.5 particulate matter, also neutralises harmful gases such as Nitrogen Dioxide (NO2).
The first product of Innonix was a cigarette filter treated with a biochemical substance to block key toxins formed during the smoking process to prevent cancer and heart disease.
The world’s first US-FDA cleared anti-viral face mask was the next product to be developed and launched. The US-FDA created a new category for this product besides developing new testing protocols. Unlike all masks in the market, besides acting as a physical barrier between the viruses & the wearer. This mask also pulls the viruses into its interior and kills 99.99% of the viruses within 5 minutes. The product has been tested against 18 different viruses, including SARS, Avian Flu, etc. The mask also kills bacteria and fungi.